MedTrace Logo

Usability and Feasibility of a Personalized, Web-based Education and Self-management Approach for Patients With Chronic Heart Failure Across Four European Sites

NCT04699253 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 542

Last updated 2024-04-17

No results posted yet for this study

Summary

The STABELISE-HF is an investigator initiated, international, multicentre feasibility study that will investigate the use of a web application called SanaCoach Heart failure in patients with chronic heart failure. SanaCoach heart failure provides patient education, systematic self-monitoring, a care plan repository and facilitates correspondence with patient's care provider.

Conditions

Interventions

DEVICE

SanaCoach Heart failure

Patients will be using the SanaCoach heart failure for at least 6 months during the study period. SanaCoach heart failure is a web application that will be guiding the patient through a regular, systematic assessment of patient's health and wellbeing as well as regular education sessions. The assessment frequency ranges from daily to monthly, based on the settings provided by the health care provider. Furthermore, it provides a repository for patient's care plan to give insight into the course and treatment of the disorder and offers the possibility to contact the health care provider through the web application.

Sponsors & Collaborators

  • RWTH Aachen University

    collaborator OTHER

  • Queen's University, Belfast

    collaborator OTHER

  • University College Dublin

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Hans-Peter Brunner-La Rocca, Prof · Maastricht University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Germany
  • Ireland
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04699253 on ClinicalTrials.gov